These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 168645)

  • 21. Clonidine in the treatment of menopausal symptoms.
    Ylikorkala O
    Ann Chir Gynaecol Fenn; 1975; 64(4):242-5. PubMed ID: 1103700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evocability of a slight positive oestrogen feedback action on LH secretion in castrated and oestrogen-primed men.
    Dörner G; Rohde W; Schnorr D
    Endokrinologie; 1975 Dec; 66(3):373-6. PubMed ID: 174906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy.
    Barlow DH; Beastall GH; Abdalla HI; Elias-Jones J; Lindsay R; Hart DM
    Br Med J (Clin Res Ed); 1985 Feb; 290(6468):589-91. PubMed ID: 3918684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in psychological well-being during postmenopause as a result of estrogen therapy.
    Durst N; Maoz B
    Maturitas; 1979 Jun; 1(4):301-15. PubMed ID: 233111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma equilin concentrations in an oophorectomized woman following ingestion of conjugated equine oestrogens (Premarin).
    Morgan MR; Whittaker PG; Dean PD; Lenton EA; Sexton L; Cooke ID
    Eur J Clin Invest; 1979 Dec; 9(6):473-4. PubMed ID: 231519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of medroxyprogesterone acetate to prevent menopausal symptoms.
    Bullock JL; Massey FM; Gambrell RD
    Obstet Gynecol; 1975 Aug; 46(2):165-8. PubMed ID: 1153148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Conjugated estrogens, estrogen excretion and antigonadotropic effect].
    Laschet U; Laschet L
    Arzneimittelforschung; 1970 Apr; 20(4):542-5. PubMed ID: 4315906
    [No Abstract]   [Full Text] [Related]  

  • 31. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
    Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
    Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The climacteric syndrome: an estrogen replacement dilemma.
    Strickler RC; Borth R; Woodlever CA
    Can Med Assoc J; 1977 Mar; 116(6):586-7. PubMed ID: 204404
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the modification of serum lipids in healthy postmenopausal women by conjugated estrogens. II].
    Florian HJ; Burger H; Holzmann G
    Z Geburtshilfe Gynakol; 1969 Apr; 170(2):118-24. PubMed ID: 4306594
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, cross-over study comparing chlordiazepoxide, conjugated estrogens, combined chlordiazepoxide and conjugated estrogens, and placebo in treatment of the menopause.
    Sheffery JB; Wilson TA; Walsh JC
    Med Ann Dist Columbia; 1969 Aug; 38(8):433-6. PubMed ID: 4307908
    [No Abstract]   [Full Text] [Related]  

  • 36. Responses of plasma LH to insulin-induced hypoglycemia, basopressin, premarin and clomiphene.
    Demura H; Demura R; Iino M; Nunokawa T; Baba H; Miura K
    Tohoku J Exp Med; 1971 Sep; 105(1):65-74. PubMed ID: 4334569
    [No Abstract]   [Full Text] [Related]  

  • 37. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T; Sakuma K; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the effects of Ayerogen with equanil sodium sulphate in climacteric women].
    Del Corral F; Zúñiga JE; Navarro H
    Rev Colomb Obstet Ginecol; 1969; 20(2):74-90. PubMed ID: 4308556
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormonal changes in the treatment of the climacteric syndrome using conjugated estrogens].
    Donát J; Jirkalová V
    Cesk Gynekol; 1986 Sep; 51(8):617-20. PubMed ID: 3022948
    [No Abstract]   [Full Text] [Related]  

  • 40. Osteoporosis, oestrogens and oöphorectomy. A proposed new test of oestrogenic potency.
    Utian WH
    S Afr Med J; 1975 Mar; 49(12):433-6. PubMed ID: 168644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.